Medigen share price spiral stretches to five daysVACCINE WORRIES: An analyst attributed the company’s declining share price to market corrections and questions over locally developed vaccines against COVID-19By Kao Shih-ching / Staff reporterMedigen Vaccine Biologics Corp’s (高端疫苗) share price yesterday plunged by the daily limit of 10 percent for the fifth consecutive day, closing at NT$230.5 amid questions over locally produced COVID-19 vaccines. However, the company’s share price has plummeted by the daily limit since Monday, closing at NT$350 on Monday, NT$315 on Tuesday, NT$284 on Wednesday and NT$256 on Thursday, the data showed. Yesterday’s closing price was down 44.8 percent from its peak last year, although it was still up 137 percent for the year to date, the data showed. In yesterday’s trading, 2.09 million shares changed hands, with foreign institutional investors buying a net 4,867 shares and dealers selling a net 28,000 shares, the data showed. In a telephone call with the Taipei Times, an analyst attributed the falling share price to market corrections and questions over locally developed COVID-19 vaccines.

Source: Taipei Times June 04, 2021 15:56 UTC